Charles Schwab’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-517,263
| Closed | -$10.4M | – | 3604 |
|
|
2021
Q3 | $10.4M | Buy |
517,263
+17,340
| +3% | +$350K | ﹤0.01% | 1982 |
|
|
2021
Q2 | $18.7M | Sell |
499,923
-40,446
| -7% | -$1.51M | 0.01% | 1632 |
|
|
2021
Q1 | $13.8M | Buy |
540,369
+20,862
| +4% | +$533K | 0.01% | 1770 |
|
|
2020
Q4 | $11.4M | Buy |
519,507
+10,269
| +2% | +$226K | ﹤0.01% | 1783 |
|
|
2020
Q3 | $9.16M | Buy |
509,238
+34,566
| +7% | +$622K | ﹤0.01% | 1755 |
|
|
2020
Q2 | $12.1M | Buy |
474,672
+120,396
| +34% | +$3.06M | 0.01% | 1522 |
|
|
2020
Q1 | $6.51M | Buy |
354,276
+31,381
| +10% | +$577K | ﹤0.01% | 1701 |
|
|
2019
Q4 | $7.11M | Sell |
322,895
-25,930
| -7% | -$571K | ﹤0.01% | 1840 |
|
|
2019
Q3 | $5.01M | Buy |
348,825
+46,488
| +15% | +$668K | ﹤0.01% | 1956 |
|
|
2019
Q2 | $4.76M | Buy |
302,337
+1,881
| +0.6% | +$29.6K | ﹤0.01% | 1993 |
|
|
2019
Q1 | $4.4M | Buy |
300,456
+17,489
| +6% | +$256K | ﹤0.01% | 2030 |
|
|
2018
Q4 | $3.03M | Buy |
282,967
+53,037
| +23% | +$567K | ﹤0.01% | 2161 |
|
|
2018
Q3 | $3.51M | Buy |
229,930
+140,430
| +157% | +$2.14M | ﹤0.01% | 2227 |
|
|
2018
Q2 | $1.1M | Buy |
+89,500
| New | +$1.1M | ﹤0.01% | 2561 |
|
|
2016
Q2 | – | Sell |
-21,814
| Closed | -$117K | – | 3153 |
|
|
2016
Q1 | $117K | Hold |
21,814
| – | – | ﹤0.01% | 2973 |
|
|
2015
Q4 | $259K | Hold |
21,814
| – | – | ﹤0.01% | 2906 |
|
|
2015
Q3 | $180K | Hold |
21,814
| – | – | ﹤0.01% | 2974 |
|
|
2015
Q2 | $305K | Buy |
+21,814
| New | +$305K | ﹤0.01% | 2872 |
|
|
2014
Q3 | – | Sell |
-10,528
| Closed | -$238K | – | 3083 |
|
|
2014
Q2 | $238K | Buy |
+10,528
| New | +$238K | ﹤0.01% | 2946 |
|